Telix Pharmaceuticals Limited Acquisitions Through Business Combinations Rightofuse Assets
Telix Pharmaceuticals Limited (TLPPF) reported Acquisitions Through Business Combinations Rightofuse Assets of $49.70 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes
ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets · last filed 2026-02-20
AUD
| Period end | Acquisitions Through Business Combinations Rightofuse Assets 12 month |
|---|---|
| 2024-12-31 | 1.69M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Acquisitions Through Business Combinations Rightofuse Assets 12 month |
|---|---|
| 2025-12-31 | $49.70M 20-F · filed 2026-02-20 |